According to Biotest 's latest financial reports the company's current EPS (TTM) is -$0.40. In 2022 the company made an earnings per share (EPS) of -$1.21 an increase over its 2021 EPS that were of -$2.64.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.40 | -66.89% |
2022 | -$1.21 | -54.27% |
2021 | -$2.64 | 99.36% |
2020 | -$1.32 | 471.15% |
2019 | -$0.23 | -103.03% |
2018 | $7.64 | -9663.05% |
2017 | -$0.07993 | -95.43% |
2016 | -$1.75 | -47.94% |
2015 | -$3.36 | -468.28% |
2014 | $0.91 | -42.66% |
2013 | $1.59 | -8.51% |
2012 | $1.74 | -31.45% |
2011 | $2.54 | 30.12% |
2010 | $1.95 | 36.09% |
2009 | $1.43 |